We would like to share with you another story highlighting the impact of treatment with anti-GD-2, a trifunctional antibody, one of the latest members of the trifunctional Ab platform. One of our patients (male, 58 yrs old) was diagnosed with melanoma and metastases to the liver, bone, spleen, lung and peritoneum. He was previously treated with chemotherapy, sorafenib, hyperthermia and dendritic cell vaccine. At the clinic, he received Anti-GD-2 treatment for 6 weeks, side effects were mild and well controlled. 10 weeks after, a PET scan was performed and already showed remarkable reduction of metastases, see images below. Anti-GD-2 treatment can be applied in many different solid tumors and can induce a therapeutic vaccination (see diagram).
Please note that the statements are original statements and were written by the individual patients themselves. A translation of these original statements is therefore not possible, so that only the originals in the language used by the patients are available.
Please note that due to the data protection law, we cannot provide any updates about past testimonials that have been published following our patients’ wishes. Furthermore, please don’t misunderstand the testimonials as an objective and complete treatment summary. In many cases, the patients use testimonials to express their gratitude to our team, as we have supported them in a very difficult situation, regardless of their treatment response. In case of a patient’s death, we cannot always publish this under the testimonial due to the data protection law. In case you are a patient or a legal representative and want to have a testimonial removed, please contact our administration: info@hallwang-clinic.com